{"name":"Shao-quan Zhang","slug":"shao-quan-zhang","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Infectious Disease","slug":"infectious-disease","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Telbivudine, Lamivudine, Adefovir ,Enecavir","genericName":"Telbivudine, Lamivudine, Adefovir ,Enecavir","slug":"telbivudine-lamivudine-adefovir-enecavir","indication":"Chronic hepatitis B infection","status":"marketed"}]}],"pipeline":[{"name":"Telbivudine, Lamivudine, Adefovir ,Enecavir","genericName":"Telbivudine, Lamivudine, Adefovir ,Enecavir","slug":"telbivudine-lamivudine-adefovir-enecavir","phase":"marketed","mechanism":"These nucleoside/nucleotide reverse transcriptase inhibitors block hepatitis B virus replication by inhibiting the viral reverse transcriptase enzyme.","indications":["Chronic hepatitis B infection","Hepatitis B with compensated liver disease","Hepatitis B with decompensated cirrhosis (entecavir, adefovir)"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFBSRThZeTNaM0F5MWJ0bnlhNjFKdnNDaDByNTZ0QWpvQU5MZk1xT2dtRU1TaUQtQllGVURjRTR4QXNmQnBab1ZJajVYbnBBQ01WXzdzZ01MSUJ0TV96TmIw?oc=5","date":"2024-05-11","type":"pipeline","source":"nature.com","summary":"Structural insights into drug transport by an aquaglyceroporin - nature.com","headline":"Structural insights into drug transport by an aquaglyceroporin","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"marketed":1},"enrichmentLevel":2,"visitCount":4,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}